Welcome to Flow Pharma Inc.

Page Loading...

Menu
blob-1
blob-2

About Us

Flow Pharma, Inc.

World Leaders in T-Cell Immunotherapy 

Engineering and Manufacturing Medicines that Treat and Prevent Disease via Selective T-Cell Stimulation

Ebola Vaccine Creator

United States Department of Defense Vaccine Contractor

Founding Member of Strategic Vaccines Public-Private Partnership

Flow Pharma, Inc. is a Cleveland Ohio based biopharmaceutical company. We utilize artificial intelligence to detect peptide targets on cancer cells and virus-infected cells. We then design, synthesize, and deliver identical peptides to stimulate therapeutic attack by the patient’s native immune system. These revolutionary T-cell stimulating therapeutic peptides can be administered by injection or inhalation to selectively stimulate precision-targeted immune response.

about us flow pharma

We recently completed pre-clinical testing of FLOVID-20, a COVID-19 immunotherapy, at the United States National Laboratory at the University of Texas in Galveston. The test results demonstrate that FLOVID-20 immunized macaque monkeys, protecting them from COVID-19.

Flow Pharma has created FlowVax Survivin, a breast cancer immuno-therapeutic, targeting a neoantigen found on malignant breast cells. Our initial animal tests demonstrate a favorable response in hormone therapy resistant malignant breast cells (triple negative breast cancer). Our additional cancer therapeutic development targets include HPV-related cancers of the cervix and head & neck.

Learn More

Get to know Flow Pharma.